JNJ JOHNSON & JOHNSON Business Restructuring 8-K Filing 2024 - Earnings and Reorganization Announcement Johnson & Johnson announced a proposed Plan of Reorganization for the resolution of ovarian cancer claims, resulting in a charge of $2.7 billion and a reduction in net earnings and EPS for the first quarter of 2024.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON